IP Library Granted Patent US 8,129,120
Granted Patent B2
US 8,129,120 · App. 11/680,447 · Granted Mar 6, 2012

Methods for genetic analysis of DNA to detect sequence variances

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,129,120
App. No.
11/680,447
Filed
Feb 28, 2007
Granted
Mar 6, 2012
Kind
B2
Art Unit
1681
USPC
435/6.12
Abstract

Methods for determining genotypes and haplotypes of genes are described. Also described are single nucleotide polymorphisms and haplotypes in the ApoE gene and methods of using that information.

Claims (9)

1. A method for determining the nucleotide present at a selected polymorphic site in a target nucleic acid molecule, the method comprising:

a) amplifying a portion of the target nucleic acid molecule comprising the selected polymorphic site using a first primer and a second primer, the second primer containing a recognition site for a first restriction enzyme and a recognition site for a second restriction enzyme, to generate amplification product containing a recognition site for the first restriction enzyme and a recognition site for the second restriction enzyme such that digestion of the amplification product with the first restriction enzyme and the second restriction enzyme generates a nucleic acid fragment containing the selected polymorphic site;

b) digesting the amplification product with the first restriction enzyme and the second restriction enzyme to generate a nucleic acid fragment containing the selected polymorphic site within a 5′ single-stranded overhang;

c) filling the recessed end corresponding to the 5′ overhang with nucleotides wherein at least one of the nucleotides is bromodeoxuridine; and

d) analyzing the nucleic acid fragment to identify the nucleotide present at the selected polymorphic site.

2. The method of claim 1 wherein the second primer comprises at least one nucleotide sequence that is not present in the target nucleic acid molecule.

3. The method of claim 2 wherein the second primer comprises 5′ nucleotide sequence that is complementary to a first portion of the target nucleic acid molecule, a 3′ nucleotide sequence that is complementary to a second portion of the target nucleic acid molecule, and a nucleotide sequence that is not complementary to the target nucleic acid molecule.

4. The method of claim 1 wherein the first restriction enzyme is a type IIS restriction enzyme.

5. The method of claim 1 wherein the step of analyzing the nucleic acid fragment to identify the nucleotide present at the selected polymorphic site comprises subjecting the nucleic acid fragment to mass spectrometry.

Assignments (3)
CHANGE OF NAME Recorded Jun 27, 2014
From: BIOSCIENCES ACQUISITION COMPANY
To: AGENA BIOSCIENCE, INC.
Reel/Frame 033248/0073 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2014
From: SEQUENOM, INC.
To: BIOSCIENCES ACQUISITION COMPANY
Reel/Frame 033182/0062 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2010
From: NUVELO, INC.
To: SEQUENOM INC.
Reel/Frame 024012/0141 →